Clinical Trials Directory

Trials / Unknown

UnknownNCT03138837

Role of 3 Tesla Diffusion Weighted Magnetic Resonance Imaging (DW-MRI) for Diagnosis Bladder Cancer Grade and Stage

Role of 3 Tesla Diffusion Weighted Magnetic Resonance Imaging (DW-MRI) for Diagnosis Bladder Cancer Grade and Stage. Potential Role of the Apparent Diffusion Coefficient (ADC) Value

Status
Unknown
Phase
Study type
Observational
Enrollment
385 (estimated)
Sponsor
Mansoura University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

assess diagnostic performance of 3-Tesla DW-MRI in detecting and staging bladder cancer and potential role of the ADC value as a biomarker reflecting histological grade and stage.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTMagnetic resonance imagingDiffusion Weighted Magnetic resonance imaging

Timeline

Start date
2017-05-15
Primary completion
2018-05-15
Completion
2018-05-15
First posted
2017-05-03
Last updated
2017-05-17

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT03138837. Inclusion in this directory is not an endorsement.

Role of 3 Tesla Diffusion Weighted Magnetic Resonance Imaging (DW-MRI) for Diagnosis Bladder Cancer Grade and Stage (NCT03138837) · Clinical Trials Directory